James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 149,526 shares at $16.06 ($2.4M) on 2021-12-15, disclosed to the SEC on 2021-12-17.
Open-market sale of $2.4M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.06 | 74,526 | $1.2M | 49.8% |
| 2 | $16.06 | 74,526 | $1.2M | 49.8% |
| 3 | $16.86 | 474 | $8K | 0.3% |
| Total | $16.06 avg | 149,526 | $2.4M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |